Vaxxinity, Inc. VAXX
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.43M | 26.81M | 28.57M | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.33M | 67.50M | 73.83M | -- | -- |
| Operating Income | -58.33M | -67.50M | -73.83M | -- | -- |
| Income Before Tax | -56.94M | -66.00M | -72.11M | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.94 | -66.00 | -72.11 | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.94M | -66.00M | -72.11M | -- | -- |
| EBIT | -58.33M | -67.50M | -73.83M | -- | -- |
| EBITDA | -56.10M | -65.19M | -71.76M | -- | -- |
| EPS Basic | -0.45 | -0.52 | -0.57 | -- | -- |
| Normalized Basic EPS | -0.28 | -0.33 | -0.36 | -- | -- |
| EPS Diluted | -0.45 | -0.52 | -0.57 | -- | -- |
| Normalized Diluted EPS | -0.28 | -0.33 | -0.36 | -- | -- |
| Average Basic Shares Outstanding | 506.50M | 505.34M | 504.64M | -- | -- |
| Average Diluted Shares Outstanding | 506.50M | 505.34M | 504.64M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |